Literature DB >> 8038339

Clarithromycin: a potent agent against infections due to Mycobacterium marinum.

E Bonnet, D Debat-Zoguereh, N Petit, I Ravaux, H Gallais.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8038339     DOI： 10.1093/clinids/18.4.664

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  [Sporotrichoid atypical mycobacterial infections. Antibiotic monotherapy].

Authors:  G Bormann; W C Marsch
Journal:  Hautarzt       Date:  2004-03       Impact factor: 0.751

2.  Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection.

Authors:  M R Weinstein; D E Low; T Mazzulli
Journal:  Can J Infect Dis       Date:  1997-05

3.  Infection of the upper extremity by Mycobacterium marinum in a 3-year-old boy--diagnosis by 16S-rDNA analysis.

Authors:  A Feddersen; J Kunkel; D Jonas; V Engel; S Bhakdi; M Husmann
Journal:  Infection       Date:  1996 Jan-Feb       Impact factor: 3.553

4.  Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones.

Authors:  Martin Bråbäck; Kristian Riesbeck; Arne Forsgren
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

5.  In vitro susceptibility of Mycobacterium ulcerans to clarithromycin.

Authors:  F Portaels; H Traore; K De Ridder; W M Meyers
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.